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Themechanisms of B cell selection in lymphoid tissues are poorly understood. In this issue, Victora
et al. (2010) use imaging of photoactivatable green fluorescent protein to define the movements of
B cells in germinal centers and provide evidence that antibody affinity maturation is driven by
competition for T cell help.Since the discovery in the 1960s that anti-
bodies undergo affinity maturation as
the immune response progresses, immu-
nologists have been fascinated by the
underlying mechanism, which is still only
partially understood. Victora et al. now
reveal the multi-day dynamics of B cell
migration at sites of antibody affinity
maturation and use this insight to further
define the selection mechanism. Their
efforts also mark a major technical
advance for the study of cell behavior in
a physiological context.
Germinal centers of lymph nodes are
a site of antibody affinity maturation.
They are seeded by small numbers of
rapidly dividing antigen-responding B
cells and form over a period of days into
structures of 10,000 cells (MacLennan,
1994). Germinal centers contain a dark
zone and a light zone (named based on-
histological staining); the former contains
mostly B cells, whereas the latter also
contains a small number of helper T cells
and follicular dendritic cells. An early
model posited that the dark zone is the
site of B cell proliferation and somatic
hypermutation of the immunoglobulin V
(variable) gene, and that the light zone
is where the newly mutated B cell
receptors (BCRs) compete for antigen
binding. B cell clones that have a strong
enough BCR signal would then receive
T cell help and survive. It was further
proposed that germinal center B cells
move cyclically between the dark and
light zones to undergo repeated rounds
of mutation and selection, with successful
selection eventually giving rise to plasma
cells and memory B cells (MacLennan,
1994).Prior imaging studies established that
germinal center B cells migrate in a
continuous manner over the processes
of antigen-bearing follicular dendritic cells
(Allen et al., 2007b; Hauser et al., 2007;
Schwickert et al., 2007). Small numbers
of B cells have been observed moving
bidirectionally between the light and
dark zones, though in these cases the
30–60 min imaging windows were insuffi-
cient to determine whether there is a
directional bias (Allen et al., 2007b;
Hauser et al., 2007; Schwickert et al.,
2007). Imaging cell interaction dynamics
further reveals that only a fraction of the
germinal center T cells are in stable
contact with B cells, despite most B and
T cells being specific for the same antigen
(Allen et al., 2007b). These observations
led to a revised model of affinity matura-
tion in which B cells are selected not
only based on receipt of a BCR signal,
but also on their ability to compete for
T cell help (Allen et al., 2007a).
In the current work, Victora et al. (2010)
obtain gene expression data for cells from
the light and dark zones. To do this they
photoactivate GFP in specific regions of
the germinal centers using two-photon
microscopy and then immediately isolate
the cells by flow cytometry (Figure 1A).
Although cells from the two regions are
similar in their overall pattern of gene
expression, consistent with previous
studies (reviewed in Allen et al., 2007a),
dark zone cells exhibit higher expression
of genes related to mitosis, whereas light
zone cells have higher expression of acti-
vation markers, cell-surface molecules,
and apoptosis regulators. The small mag-
nitude of these gene expression differ-Cell 143, Nences might reflect heterogeneity within
the cell populations. Indeed, previous
findings indicate that a minority of light
zone cells exhibit plasma cell properties
and nuclear localization of the transcrip-
tion factor NF-kB (Allen et al., 2007a;
Basso et al., 2004).
Victora et al. take advantage of differ-
ences in the expression of cell-surface
markers (specifically CD83, CD86, and
the chemokine receptor CXCR4) to
convincingly identify dark and light zone
cells by flow cytometry. The authors find
that both zones have cells in S phase, in
agreement with other studies (Allen et al.,
2007a), whereas almost all G2/M phase
cells are restricted to the dark zone.
Although this is consistent with long-held
views, other studies have identified occa-
sional cells undergoing mitosis in the light
zone (Allen et al., 2007a). It is notable
that the immunization strategy employed
by Victora et al. to induce germinal
center formation avoids use of adjuvant.
Perhaps the level of innate immune stimuli
accounts for these potential differences
in the behavior of light zone cells.
A major achievement of the photoacti-
vation analysis by Victora et al. is the
tracking of cell population behavior over
many hours. They show that dark zone
cells move to the light zone at a rate that
replaces much of this compartment in
6 hr; movement from the light zone to
the dark zone also occurs but is less
prominent. These compelling data pro-
vide quantitative insight into the net flux
of cells between zones and suggest that
movement from the light zone to the
dark zone is possible only for a selected
subset of cells.ovember 12, 2010 ª2010 Elsevier Inc. 503
Figure 1. Germinal Center Dynamics
(A) Transgenic B cells expressing photoactivatible-green fluorescent protein (GFP) are transferred to wild-type hosts in which germinal centers are subsequently
induced by immunization. GFP is selectively photoactivated in the dark zone (left) or light zone (right) by two-photon laser scanning microscopy. The entire lymph
node is then converted to a cell suspension, andGFP-expressing cells are isolated by flow cytometry. Alternatively, the lymph node is examined at 1 hr intervals to
record the movements of photoactivated B cells.
(B) Increased peptide loading ontomajor histocompatibility complex II (MHC II) is sufficient to give B cells a competitive advantage. Amouse containing amixture
of wild-type and DEC205-deficient B cells is immunized with antigen. After the germinal center has formed, themouse is treatedwith DEC205 antibody coupled to
antigen. The diagram shows awild-type and DEC205-deficient B cell binding the same amount of antigen in the light zone via their B cell receptors (BCRs), but the
wild-type cell also acquires antigen via DEC205, thus taking up more antigen and generating a greater number of MHC II peptide complexes compared to the
DEC205-deficient cell. As a result it receives a greater level of survival and proliferation signals from helper T cells.To test themodel that germinal center B
cells compete for T cell help, the authors
use an approach to modulate the
amount of peptide bound-major histo-
compatibiltiy complex II (MHC II) on B
cells. In previous work, Nussenzweig,
Steinman, and coworkers demonstrated
that DEC205 antibody-antigen conju-
gates efficiently target antigens to
dendritic cells for presentation to T cells.
Conveniently, Victora et al. find that
germinal center B cells also express
DEC205, and they show that the same
antigen-loading ‘‘trick’’ works to increase
peptide-MHC II abundance within 6 hr
on wild-type germinal center B cells (Vic-
tora et al., 2010). When immunized mice
harboring a mixture of wild-type and
DEC205-deficient B cells are treated
with DEC205 antibody coupled to the
relevant T cell antigen, there is an early
accumulation of DEC205-positive B cells
in the light zone (at 12 hr) followed by
a remarkable enrichment in the dark504 Cell 143, November 12, 2010 ª2010 Elsezone by 36–48 hr. The authors note that
the DEC205-negative majority is counter-
selected by focusing T cell help on a
small subset of DEC205-positive cells,
concluding that T cell help is limiting for
clonal expansion (Figure 1B). Although
the cell frequency data are clear, the
conclusion that cells with high amounts
of peptide-MHC II complexes displace
cells with less will be made still stronger
when effects on absolute cell number
are determined. Strikingly, the cells
loaded with antigen via DEC205 fail to
undergo affinity maturation, suggesting
that when cells are equivalent in their
ability to receive T cell help, differential
BCR engagement is not sufficient to
mediate affinity-based selection (Victora
et al., 2010).
The new findings, combined with the
large body of prior information, support
a model in which light zone cells gather
antigen via their BCRs as they move
over the network of follicular dendriticvier Inc.cells, with cells that have higher affinity
acquiring greater amounts of antigen per
unit time. Higher antigen uptake via the
BCR then leads to greater presentation
of peptide-MHC II complexes (Batista
and Neuberger, 1998). T cells are thought
to reorient toward cells with the highest
peptide-MHC II levels (Depoil et al.,
2005), forming stable conjugates with
the cells that have captured and pro-
cessed the most antigen, and delivering
CD40 ligand and cytokine signals essen-
tial for selection (Figure 1B).
By turning on a light in germinal center
B cells, Victora and colleagues open
a new chapter in the study of antibody
affinity maturation. Of course, many ques-
tions remain. Do B cells with high affinity
display greater amounts of peptide-
MHC II complexes than low-affinity cells?
How do T cells behave as they encounter
B cells displaying different amounts of
peptide-MHC II complexes? And how do
T cells assist in the decision of a B cell
to differentiate into an antibody-secreting
cell or return to the dark zone? In addition
to providing a platform for addressing
these questions, the powerful application
of photoactivatable-GFP in this study
should spur broader use of this tech-
nology to relate cell location with gene
expression and cell fate.ACKNOWLEDGMENTS
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Perception of pain involves both the peripheral and central nervous systems. Starting with a whole-
genomeRNA interference screen inDrosophila, Neely et al. (2010) identify amammalian gene that is
required not only for efficient transfer of pain signals between brain centers, but also for the
suppression of inappropriate signaling between other sensory systems.Even though humanity’s attempts to
control pain can be traced back through
the millennia, much of our current arsenal
of therapies still has its roots in folk
remedies. Originally derived from natural
plant products such as willow bark and
poppies, these medicines have been the
mainstay of chronic pain control for
many years. Unfortunately, even modern
therapies for chronic pain are too often
ineffective, leaving untold numbers of indi-
viduals suffering worldwide. As we move
into the postgenomic era, hopes have
been raised that the problem of pain will
be solved, largely by getting to grips with
the underlying genetic, molecular, and
cellular mechanisms involved in nocicep-
tion. It is also expected that interindividual
variability in pain experience, a major
issue confounding effective treatment,
will be accounted for in some part by vari-
ations in a definable subset of genes.
The report by Neely et al. (2010) in this
issue of Cell represents a major advancein the search for the genes and mecha-
nisms of pain and variability in its
perception. In an impressively multifac-
eted study that extends from fruit flies to
mice and ultimately to humans, the
authors have uncovered a new molecular
player, a2d3, in pain. Along the way, they
also made some highly unexpected
observations indicating that a2d3 is not
only involved in pain, but also plays
a role in the poorly understood mecha-
nisms that separate one form of sensory
information from another.
The fruit fly provides an ideal model
for unraveling genetic aspects of human
disease, with advantages including a
short generation time and the capacity
to analyze extremely large numbers of
animals in a high-throughput manner.
Genome-wide RNA interference (RNAi)
screens are a powerful investigative tool
given the fly’s relatively small (15,000
genes) but extremely well-annotated
genome and sufficient homology withthe human genome to permit the identifi-
cation of conserved pathways in flies
and humans.
In a Herculean undertaking, Neely et al.
take advantage of the Vienna global
Drosophila RNAi library (Dietzl et al.,
2007) to individually knock down almost
every gene in the fly genome, specifically
in neural tissues. Each line was then
painstakingly tested using a behavioral
assay to measure sensitivity to noxious
heat. In total, 580 genes are identified
that potentially regulate thermal nocicep-
tion and possibly basic neuronal function.
One of the genes identified is straight-
jacket, which is one of several a2d genes
that encode calcium channel subunits.
Themammalian homolog of straightjacket
is CACNAD2D3, which encodes the a2d3
subunit. Of interest, a close relative of this
protein, a2d1, is the molecular target for
the analgesics gabapentin and pregabalin
(Field et al., 2006). To further investigate
the function of a2d3, the authorsovember 12, 2010 ª2010 Elsevier Inc. 505
